Evidence map›Paper›PMID 24445304›Full record

ReviewMarine drugs2014

Thiopeptide antibiotics: retrospective and recent advances.

Xavier Just-Baringo, Fernando Albericio, Mercedes Álvarez

Abstract readReview
In one paragraph

Review in Marine drugs, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. NewTheScientificWorldJournal · 2025
    Pooled it
  2. Review
  3. Article
  4. Genomic and phenotypic insights into Serratia interaction with plants from an ecological perspective.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Therapies from Thiopeptides.Molecules (Basel, Switzerland) · 2023
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Antibacterial Thiopeptide GE2270-Congeners fromMolecules (Basel, Switzerland) · 2022
    Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xavier Just-BaringoInstitute for Research in Biomedicine, Barcelona Science Park-University of Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain.
Fernando AlbericioInstitute for Research in Biomedicine, Barcelona Science Park-University of Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain. albericio@irbbarcelona.org.
Mercedes ÁlvarezInstitute for Research in Biomedicine, Barcelona Science Park-University of Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain. mercedes.alvarez@irbbarcelona.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thiopeptides, or thiazolyl peptides, are a relatively new family of antibiotics that already counts with more than one hundred different entities. Although they are mainly isolated from soil bacteria, during the last decade, new members have been isolated from marine samples. Far from being limited to their innate antibacterial activity, thiopeptides have been found to possess a wide range of biological properties, including anticancer, antiplasmodial, immunosuppressive, etc. In spite of their ribosomal origin, these highly posttranslationally processed peptides have posed a fascinating synthetic challenge, prompting the development of various methodologies and strategies. Regardless of their limited solubility, intensive investigations are bringing thiopeptide derivatives closer to the clinic, where they are likely to show their veritable therapeutic potential.

Indexed as

AnimalsAnti-Bacterial AgentsBacteriaDrug IndustryHumansMarine BiologyMicrobial Sensitivity TestsPeptidesProtein BindingProtein ConformationVeterinary DrugsAnti-Bacterial AgentsPeptidesVeterinary Drugs

Identifiers

PMID24445304
PMCPMC3917276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.